The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial)
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Kuo, W. T., Gould, M. K., Louie, J. D., Rosenberg, J. K., Sze, D. Y., & Hofmann, L. V. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.08.002 · Cited by 504
Research works printed but not linked: 15
- Wan, 2004, Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials, Circulation, 110, 744, 10.1161/01.CIR.0000137826.09715.9C · DOI · Paper page
- Jaff, 2011, Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association, Circulation, 123, 1788, 10.1161/CIR.0b013e318214914f · DOI · Paper page
- Konstantinides, 1997, Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry, Circulation, 96, 882, 10.1161/01.CIR.96.3.882 · DOI · Paper page
- Konstantinides, 2002, Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism, N Engl J Med, 347, 1143, 10.1056/NEJMoa021274 · DOI · Paper page
- Berkowitz, 1997, Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction, Circulation, 95, 2508, 10.1161/01.CIR.95.11.2508 · DOI · Paper page
- Sharifi, 2012, Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion “TORPEDO” trial: mid-term results, J Endovasc Ther, 19, 273, 10.1583/11-3674MR.1 · DOI
- Kline, 2009, Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure, Chest, 136, 1202, 10.1378/chest.08-2988 · DOI
- Sharma, 2000, Long-term benefit of thrombolytic therapy in patients with pulmonary embolism, Vasc Med, 5, 91, 10.1177/1358836X0000500205 · DOI
- Schwarz, 1985, Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism, Circulation, 71, 117, 10.1161/01.CIR.71.1.117 · doi:10.1161/01.cir.71.1.117
- De Soyza, 1972, Persistent post-embolic pulmonary hypertension, Chest, 62, 665, 10.1378/chest.62.6.665 · doi:10.1378/chest.62.6.665
- Levine, 1995, Thrombolytic therapy for venous thromboembolism, Clin Chest Med, 16, 321, 10.1016/S0272-5231(21)01095-9 · DOI
- Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 · DOI · Paper page
- Dalen, 1997, Thrombolytic therapy for pulmonary embolism. Is it effective? Is it safe? When is it indicated?, Arch Intern Med, 157, 2550, 10.1001/archinte.1997.00440430026003 · doi:10.1001/archinte.1997.00440430026003
- Boone, 2011, The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation, Anesth Analg, 112, 319, 10.1213/ANE.0b013e31820472d4 · doi:10.1213/ane.0b013e31820472d4
- Chamsuddin, 2008, Catheter-directed thrombolysis with the Endowave system in the treatment of acute massive pulmonary embolism: a retrospective multicenter case series, J Vasc Interv Radiol, 19, 372, 10.1016/j.jvir.2007.10.019 · DOI
Cited by
Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Ortel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
“We identified 29 systematic reviews(151-179) and 26 RCTs (n 5 2787).(130,180-204) Trials included individuals with an objectively confirmed symptomatic PE.”
BackgroundAntithrombotic Therapy for VTE Disease
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G.-J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., et al. (2021) · Chest · doi:10.1016/j.chest.2021.07.055 · Cited by 1,043
Metadata
- Authors
- Sharifi, M., Bay, C., Skrocki, L., Rahimi, F., & Mehdipour, M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 111
- Issue
- 2
- Pages
- 273-277
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2024687690
- Cited by
- 582
- References
- 3
- FWCI
- 19.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). https://app.cochat.ai/papers/10.1016/j.amjcard.2012.09.027
- The paper
- Sharifi, M., Bay, C., Skrocki, L., Rahimi, F., & Mehdipour, M. (2013). Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). The American Journal of Cardiology. https://doi.org/10.1016/j.amjcard.2012.09.027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
